Fineline Cube

Follow:
14398 Articles
Kanghong Pharmaceutical's NASH Drug KH629 Approved for Clinical Trials in China
CompanyDrug

Kanghong Pharmaceutical’s NASH Drug KH629 Approved for Clinical Trials in China

Huadong Medicine Gets Green Light for HPK1 PROTAC Drug HDM2006 in Advanced Solid Tumors
CompanyDrug

Huadong Medicine Gets Green Light for HPK1 PROTAC Drug HDM2006 in Advanced Solid Tumors

China's NHSA Concludes Pre-Negotiation Talks for National Reimbursement Drug List
Policy / Regulatory

China’s NHSA Concludes Pre-Negotiation Talks for National Reimbursement Drug List

Astellas Pharma's Vyloy Receives FDA Approval for Gastric Cancer Treatment in CLDN18.2 Positive Tumors
CompanyDrug

Astellas Pharma’s Vyloy Receives FDA Approval for Gastric Cancer Treatment in CLDN18.2 Positive Tumors

Gilead Sciences to Withdraw Accelerated Approval of Trodelvy in Urothelial Carcinoma
CompanyDrug

Gilead Sciences to Withdraw Accelerated Approval of Trodelvy in Urothelial Carcinoma

Jiangsu Hengrui Medicine Initiates Phase III Clinical Trial for SHR-A1904 in Gastric Cancer
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Initiates Phase III Clinical Trial for SHR-A1904 in Gastric Cancer

MicroPort Sorim CRM's PLATINIUM Series ICD Receives NMPA Approval, A First for China
CompanyMedical Device

MicroPort Sorim CRM’s PLATINIUM Series ICD Receives NMPA Approval, A First for China

Jacobio Pharma's G12C Inhibitor Gecirasib Earns Orphan Drug Designation in Europe for Pancreatic Cancer
CompanyDrug

Jacobio Pharma’s G12C Inhibitor Gecirasib Earns Orphan Drug Designation in Europe for Pancreatic Cancer

MicroPort NeuroTech's NUMEN Silk Receives FDA Approval for Embolization Treatment
CompanyDrug

MicroPort NeuroTech’s NUMEN Silk Receives FDA Approval for Embolization Treatment

Astellas Pharma's Vyloy Receives FDA Approval for CLDN18.2 Positive Gastric Cancer Treatment
CompanyDrug

Astellas Pharma’s Vyloy Receives FDA Approval for CLDN18.2 Positive Gastric Cancer Treatment

Westgene Biopharma's Pioneering mRNA Vaccine for EBV-Related Tumors Clears IND Hurdle in China
CompanyDrug

Westgene Biopharma’s Pioneering mRNA Vaccine for EBV-Related Tumors Clears IND Hurdle in China

Kanghong Pharmaceutical's NASH Drug KH629 Receives Clinical Trial Implicit Approval in China
CompanyDrug

Kanghong Pharmaceutical’s NASH Drug KH629 Receives Clinical Trial Implicit Approval in China